H Kunhiparambath

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
e11552 Background: Studies describing outcomes for phyllodes tumor of the breast are scarce. We explored the results of multimodality management at our institute for this disease. METHODS We retrospectively analysed our database for cases between 1994 & 2009. Adjuvant radiation was 50 Gy in 25 fractions after modified radical mastectomy (MRM) or 66 Gy(More)
e11543 Background: Triple negative breast cancer (TNBC) is a distinct entity associated with adverse outcomes. We explore our institutional results. METHODS We retrospectively analysed our database between 2000 & 2010. The estrogen receptor (ER) & progesterone receptor (PR) status was negative by immunohistochemistry (IHC) while Her2 status was negative(More)
e16158 Background: Intensity Modulated Radiotherapy (IMRT) is used in carcinoma prostate to achieve better target coverage with less dose to critical organs thereby permitting dose escalation and eventually better therapeutic ratio. There is scarcity of literature evaluating beam number and energy in prostate cancer treated by IMRT. Aim of our study is to(More)
e15187 Background: Oncentra Prostate real-time system for HDR prostate implants consists of most advanced inverse planning tools which assures rapid achievement of required dosimetric parameters. This system consists of various optimization tools in which we compared multi-solution variance based optimization and multi-solutions dose volume histogram based(More)
e15109 Background: Ultrasound-based real time HDR brachytherapy planning is a recent advance in prostate brachytherapy. There are a number of optimization methods in Oncentra Prostate (previously SWIFT). We have compared two most important optimization methods: single objective dose volume histogram-based inverse planning optimization (SDVHO-IP) versus(More)
  • 1